Presented for research literature review only Abdel-aleem S et al
Praise for Becky Dorner & Associates Guidance for Evaluation and Management of GERD- Short Course Emma Fogt, MBA, MS, RDN, FAND Minimum Data Set 3.0 Resident Assessment Instrument Manual v1.19.1 (October 2024) Self-Study Course Doreen Rodo, MEd, RDN, LDN Sports Nutrition for the Nutrition Professional Course Kelly Pritchett, PhD, RDN, CSSD GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition Aimee Shea, MPH, RDN, CCMS, LD Policy & Procedure Manual: For Nutrition and Food Service in Healthcare Facilities, 2023 Katy Adams, MDA, RD, CSG, LD Managing Chronic Kidney Disease with the Nutrition Care Process Course Nadia Marzella, MS, RDN, CSR, LD
While GLP-1 clearly affects appetite centers in the brain, adding GIP agonism might influence different neural circuits related to food reward, energy expenditure, or metabolic regulation
I had already been taking 500-1000 mg of carnitine per day (500 mg has been the studied dose in pregnancy research I have seen), but perhaps 2000 mg may have been a more appropriate amount to take due to my history of Hashimotos, and because I had to increase thyroid hormones while pregnant
Those findings relate to the specific FDA-approved medication and study protocol evaluated by researchers